drugset / Trial / NCT03721328

Safety and Efficacy in Patients Treated for Hip or Knee PJI With Vancomycin and Tobramycin Joint Irrigation

NCT03721328

Phase 2 Completed 15 enrolled Osteal Therapeutics, Inc.
NaSingle-groupOpen-labelTreatment

Summary

Study Type Prospective, single-arm, open-label, multicenter (3 to 5 sites), interventional trial. Primary Study Objective The objective of the study is to determine the safety profile of local antibiotic irrigation for the treatment of PJI. Primary Outcome Measure The overall safety profile is characterized by assessing the incidence of adverse events (AEs), serious adverse events (SAEs), suspected adverse reactions, adverse reactions, and unexpected adverse reactions. Follow-up Patients will be assessed for all measures at 3 weeks, 6 weeks, 12 weeks, and 12 months from initial surgery.

Timeline

Start
2018-10-26
Primary completion
2020-08-25
Completion
2020-08-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Tobramycin Small molecule Other
Subject Vancomycin Other / unclassified Other